tiprankstipranks
Trending News
More News >
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Japanese Market

Taiko Pharmaceutical Co., Ltd. (4574) Income Statement

Compare
0 Followers

Taiko Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2025), Taiko Pharmaceutical Co., Ltd.'s total revenue was ¥1.26B, a decrease of -14.90% from the same quarter last year. In Q2, Taiko Pharmaceutical Co., Ltd.'s net income was ¥-13.00M. See Taiko Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 6.29B¥ 6.12B¥ 5.04B¥ 10.72B¥ 17.68B
Gross Profit
¥ 3.67B¥ 2.58B¥ 1.08B¥ 2.75B¥ 12.42B
Operating Expenses
¥ 3.04B¥ 3.58B¥ 4.16B¥ 7.69B¥ 6.77B
Depreciation and Amortization
¥ 256.00M¥ 704.00M¥ -671.00M¥ -620.00M¥ 272.52M
EBITDA
¥ 882.00M¥ -2.85B¥ -3.75B¥ -5.57B¥ 5.92B
Operating Income
¥ 629.00M¥ -1.00B¥ -3.08B¥ -4.95B¥ 5.65B
Other Income/Expenses
¥ -64.00M¥ -2.56B¥ -1.79B¥ -3.94B¥ -276.72M
Pretax Income
¥ 565.00M¥ -3.56B¥ -4.87B¥ -8.89B¥ 5.37B
Net Income
¥ 898.00M¥ -3.61B¥ -4.89B¥ -9.59B¥ 3.85B
Per Share Metrics
Basic EPS
¥ 17.89¥ -76.25¥ -112.24¥ -220.48¥ 89.18
Diluted EPS
¥ 17.89¥ -76.25¥ -112.24¥ -220.48¥ 88.82
Weighted Average Shares Outstanding
50.18M 47.36M 43.60M 43.51M 43.19M
Weighted Average Shares Outstanding (Diluted)
50.18M 47.36M 43.60M 43.51M 43.36M
Currency in JPY

Taiko Pharmaceutical Co., Ltd. Earnings and Revenue History